Fig. 1From: Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging studyStudy design flowchart. *BCR = biochemical recurrence of disease (intended as an increase in serum PSA levels of > 25% and/or an absolute increase of > 2 ng/mL from the nadir documented after initiation of ARSi)Back to article page